0

Journal Articles

in Tobacco
 121-140 of 298 Articles
Commentary |  July 04, 2007
Public Health Benefits of Recent Litigation Against the Tobacco Industry
Jon S. Vernick, JD, MPH; Lainie Rutkow, JD, MPH; Stephen P. Teret, JD, MPH
JAMA. 2007;298(1):86-89. doi:10.1001/jama.298.1.86.
From the Centers for Disease Control and Prevention |  July 04, 2007 FREE
Exposure to Secondhand Smoke Among Students Aged 13-15 Years—Worldwide, 2000-2007
JAMA. 2007;298(1):33-36. doi:10.1001/jama.298.1.34.
Capitol Health Call |  April 11, 2007
FDA and Tobacco
JAMA. 2007;297(14):1541. doi:10.1001/jama.297.14.1541-d.
Grand Rounds |  January 24, 2007
Inflammatory Abdominal Aortic Aneurysm
David B. Hellmann, MD; David J. Grand, MD; Julie A. Freischlag, MD
JAMA. 2007;297(4):395-400. doi:10.1001/jama.297.4.395.
INCLUDES: CME
Health Agencies Update |  January 24, 2007
Tobacco Addiction
JAMA. 2007;297(4):354. doi:10.1001/jama.297.4.354-c.
Original Contribution |  January 17, 2007 FREE
Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries
Prashant Joshi, MD; Shofiqul Islam, MSc; Prem Pais, MD; et al.
JAMA. 2007;297(3):286-294. doi:10.1001/jama.297.3.286.
From the Centers for Disease Control and Prevention |  December 27, 2006 FREE
State Medicaid Coverage for Tobacco-Dependence Treatments—United States, 2005
JAMA. 2006;296(24):2917-2920. doi:10.1001/jama.296.24.2917.
From the Centers for Disease Control and Prevention |  December 20, 2006 FREE
State-Specific Prevalence of Current Cigarette Smoking Among Adults and Secondhand Smoke Rules and Policies in Homes and Workplaces—United States, 2005
JAMA. 2006;296(23):2792-2795. doi:10.1001/jama.296.23.2792-b.
Capitol Health Call |  December 13, 2006
Health Initiatives
JAMA. 2006;296(22):2670. doi:10.1001/jama.296.22.2670-d.
Commentary |  November 22, 2006
Potential for Genetics to Promote Public Health:  Genetics Research on Smoking Suggests Caution About Expectations
Chris Carlsten, MD, MPH; Wylie Burke, MD, PhD
JAMA. 2006;296(20):2480-2482. doi:10.1001/jama.296.20.2480.
INCLUDES: CME
Original Contribution |  November 15, 2006 FREE
Midlife Risk Factors and Healthy Survival in Men
Bradley J. Willcox, MD; Qimei He, PhD; Randi Chen, MS; et al.
JAMA. 2006;296(19):2343-2350. doi:10.1001/jama.296.19.2343.
Editorial |  October 11, 2006
Banning Smoking in Public Places:  Time to Clear the Air
Mark D. Eisner, MD, MPH
JAMA. 2006;296(14):1778-1779. doi:10.1001/jama.296.14.1778.
Original Contribution |  October 11, 2006 FREE
Respiratory Symptoms, Pulmonary Function, and Markers of Inflammation Among Bar Workers Before and After a Legislative Ban on Smoking in Public Places
Daniel Menzies, MBChB; Arun Nair, MBBS; Peter A. Williamson, MBChB; et al.
JAMA. 2006;296(14):1742-1748. doi:10.1001/jama.296.14.1742.
Medical News and Perspectives |  August 23, 2006
Report Reviews Secondhand Smoke Risks
JAMA. 2006;296(8):913-923. doi:10.1001/jama.296.8.922.
From the Centers for Disease Control and Prevention |  August 23, 2006 FREE
Cigarette Use Among High School Students—United States, 1991-2005
JAMA. 2006;296(8):925-928. doi:10.1001/jama.296.8.927.
The World in Medicine |  July 19, 2006
Parental Smoking
JAMA. 2006;296(3):272. doi:10.1001/jama.296.3.272-b.
Original Contribution |  July 12, 2006 FREE
Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer
International Early Lung Cancer Action Program Investigators*
JAMA. 2006;296(2):180-184. doi:10.1001/jama.296.2.180.
Editorial |  July 05, 2006
Varenicline for Smoking Cessation:  Definite Promise, But No Panacea
Robert C. Klesges, PhD; Karen C. Johnson, MD, MPH; Grant Somes, PhD
JAMA. 2006;296(1):94-95. doi:10.1001/jama.296.1.94.
Original Contribution |  July 05, 2006 FREE
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation:  A Randomized Controlled Trial
David Gonzales, PhD; Stephen I. Rennard, MD; Mitchell Nides, PhD; et al.
JAMA. 2006;296(1):47-55. doi:10.1001/jama.296.1.47.
Original Contribution |  July 05, 2006 FREE
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation:  A Randomized Controlled Trial
Douglas E. Jorenby, PhD; J. Taylor Hays, MD; Nancy A. Rigotti, MD; et al.
JAMA. 2006;296(1):56-63. doi:10.1001/jama.296.1.56.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program
Sengwee Toh, ScD; Meghan A. Baker, MD, ScD; Jeffrey S. Brown, PhD; et al.
JAMA Internal Medicine
Original Investigation  |  April 8, 2013
Forced Smoking Abstinence:  Not Enough for Smoking Cessation
Jennifer G. Clarke, MD, MPH; L. A. R. Stein, PhD; Rosemarie A. Martin, PhD; et al.
JAMA Internal Medicine
Invited Commentary  |  April 8, 2013
Improving Health Care After Prison
Comment on “Forced Smoking Abstinence: Not Enough for Smoking Cessation”
Michael Puisis, DO
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Causal Effect of Public Space Smoking Bans?
Marco D. Huesch, MBBS, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems